Functional characterization of HIV-1 Nef mutants in the context of viral infection

Virology

Volumn 351, Issue 2, 2006, Pages 322-339

  Fackler, Oliver T ^a   Moris, Arnaud ^b   Tibroni, Nadine ^a   Giese, Simone I ^a   Glass, Bärbel ^a   Schwartz, Olivier ^b   Kräusslich, Hans Georg ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSTITUT PASTEUR   (France)

Author keywords

Cell surface receptor modulation; HIV Nef; Infectivity; Mutant virus panel; Myristoylation; Replication; Virion incorporation

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; PROTEIN SH3; TRANSCRIPTION FACTOR AP 1;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MYRISTYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; T LYMPHOCYTE; VIRION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE;

ANTIGENS, CD4; CELL LINE; GENE EXPRESSION REGULATION; GENE PRODUCTS, NEF; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; LYMPHOCYTES; MUTATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33746322762     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.03.044     Document Type: Article

References (94)

1. Aiken C., and Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69 8 (1995) 5048-5056
2. Aldrovandi G.M., Gao L., Bristol G., and Zack J.A. Regions of human immunodeficiency virus type 1 nef required for function in vivo. J. Virol. 72 9 (1998) 7032-7039
3. Alland L., Peseckis S.M., Atherton R.E., Berthiaume L., and Resh M.D. Dual myristoylation and palmitylation of Src family member p59fyn affects subcellular localization. J. Biol. Chem. 269 24 (1994) 16701-16705
4. Arold S.T., and Baur A.S. Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem. Sci. 26 6 (2001) 356-363
5. Arora V.K., Fredericksen B.L., and Garcia J.V. Nef: agent of cell subversion. Microbes Infect. 4 2 (2002) 189-199
6. Baur A.S., Sawai E.T., Dazin P., Fantl W.J., Cheng-Mayer C., and Peterlin B.M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1 5 (1994) 373-384
7. Baur A.S., Sass G., Laffert B., Willbold D., Cheng-Mayer C., and Peterlin B.M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6 3 (1997) 283-291
8. Benson R.E., Sanfridson A., Ottinger J.S., Doyle C., and Cullen B.R. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177 6 (1993) 1561-1566
9. Bentham M., Mazaleyrat S., and Harris M. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J. Gen. Virol. 87 Pt. 3 (2006) 563-571
10. Blagoveshchenskaya A.D., Thomas L., Feliciangeli S.F., Hung C.H., and Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111 6 (2002) 853-866
11. Bresnahan P.A., Yonemoto W., Ferrell S., Williams-Herman D., Geleziunas R., and Greene W.C. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr. Biol. 8 22 (1998) 1235-1238
12. Bukovsky A.A., Dorfman T., Weimann A., and Gottlinger H.G. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 71 2 (1997) 1013-1018
13. Cavrois M., Neidleman J., Yonemoto W., Fenard D., and Greene W.C. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. Virology 328 1 (2004) 36-44
14. Chen B.K., Gandhi R.T., and Baltimore D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70 9 (1996) 6044-6053
15. Chen Y.L., Trono D., and Camaur D. The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity. J. Virol. 72 4 (1998) 3178-3184
16. Choi J., Walker J., Boichuk S., Kirkiles-Smith N., Torpey N., Pober J.S., and Alexander L. Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo. J. Virol. 79 1 (2005) 264-276
17. Coates K., Cooke S.J., Mann D.A., and Harris M.P. Protein kinase C-mediated phosphorylation of HIV-I nef in human cell lines. J. Biol. Chem. 272 19 (1997) 12289-12294
18. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., and Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391 6665 (1998) 397-401
19. Costa L.J., Zheng Y.H., Sabotic J., Mak J., Fackler O.T., and Peterlin B.M. Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1. J. Virol. 78 10 (2004) 5311-5323
20. Craig H.M., Pandori M.W., and Guatelli J.C. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 95 19 (1998) 11229-11234
21. Craig H.M., Reddy T.R., Riggs N.L., Dao P.P., and Guatelli J.C. Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology 271 1 (2000) 9-17
22. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D.A., Greenway A.L., Ellett A., Chatfield C., et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270 5238 (1995) 988-991
23. Erdtmann L., Janvier K., Raposo G., Craig H.M., Benaroch P., Berlioz-Torrent C., Guatelli J.C., Benarous R., and Benichou S. Two independent regions of HIV-1 Nef are required for connection with the endocytic pathway through binding to the mu 1 chain of AP1 complex. Traffic 1 11 (2000) 871-883
24. Fackler O.T., and Baur A.S. Live and let die: Nef functions beyond HIV replication. Immunity 16 4 (2002) 493-497
25. Fackler O.T., and Peterlin B.M. Endocytic entry of HIV-1. Curr. Biol. 10 16 (2000) 1005-1008
26. Fackler O.T., Kremmer E., and Mueller-Lantzsch N. Evidence for the association of Nef protein with HIV-2 virions. Virus Res. 46 1-2 (1996) 105-110
27. Fackler O.T., Kienzle N., Kremmer E., Boese A., Schramm B., Klimkait T., Kucherer C., and Mueller-Lantzsch N. Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur. J. Biochem. 247 3 (1997) 843-851
28. Fackler O.T., Luo W., Geyer M., Alberts A.S., and Peterlin B.M. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 3 6 (1999) 729-739
29. Fackler O.T., Lu X., Frost J.A., Geyer M., Jiang B., Luo W., Abo A., Alberts A.S., and Peterlin B.M. p21-activated kinase 1 plays a critical role in cellular activation by Nef. Mol. Cell. Biol. 20 7 (2000) 2619-2627
30. Fackler O.T., Wolf D., Weber H.O., Laffert B., D'Aloja P., Schuler-Thurner B., Geffin R., Saksela K., Geyer M., Peterlin B.M., Schuler G., and Baur A.S. A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells. Curr. Biol. 11 16 (2001) 1294-1299
31. Garcia J.V., and Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350 6318 (1991) 508-511
32. Geyer M., Fackler O.T., and Peterlin B.M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2 7 (2001) 580-585
33. Glushakova S., Munch J., Carl S., Greenough T.C., Sullivan J.L., Margolis L., and Kirchhoff F. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo. J. Virol. 75 21 (2001) 10113-10117
34. Greenberg M., DeTulleo L., Rapoport I., Skowronski J., and Kirchhausen T. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr. Biol. 8 22 (1998) 1239-1242
35. Greenberg M.E., Iafrate A.J., and Skowronski J. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17 10 (1998) 2777-2789
36. Grzesiek S., Stahl S.J., Wingfield P.T., and Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35 32 (1996) 10256-10261
37. Hanna Z., Kay D.G., Rebai N., Guimond A., Jothy S., and Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95 2 (1998) 163-175
38. Hanna Z., Priceputu E., Kay D.G., Poudrier J., Chrobak P., and Jolicoeur P. In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice. Virology 327 2 (2004) 273-286
39. Hill B.T., and Skowronski J. Human N-myristoyl transferases form stable complexes with lentiviral nef and other viral and cellular substrate proteins. J. Virol. 79 2 (2005) 1133-1141
40. Hodge D.R., Dunn K.J., Pei G.K., Chakrabarty M.K., Heidecker G., Lautenberger J.A., and Samuel K.P. Binding of c-Raf1 kinase to a conserved acidic sequence within the carboxyl-terminal region of the HIV-1 Nef protein. J. Biol. Chem. 273 25 (1998) 15727-15733
41. Iafrate A.J., Bronson S., and Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16 4 (1997) 673-684
42. Janvier K., Craig H., Hitchin D., Madrid R., Sol-Foulon N., Renault L., Cherfils J., Cassel D., Benichou S., and Guatelli J. HIV-1 Nef stabilizes the association of adaptor protein complexes with membranes. J. Biol. Chem. 278 10 (2003) 8725-8732
43. Kasper M.R., and Collins K.L. Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J. Virol. 77 5 (2003) 3041-3049
44. Keppler O.T., Allespach I., Schuller L., Fenard D., Greene W.C., and Fackler O.T. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 79 3 (2005) 1655-1665
45. Kestler III H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 4 (1991) 651-662
46. Khan M., Garcia-Barrio M., and Powell M.D. Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription. J. Virol. 75 24 (2001) 12081-12087
47. Khan M., Jin L., Miles L., Bond V.C., and Powell M.D. Chimeric human immunodeficiency virus type 1 virions that contain the simian immunodeficiency virus nef gene are cyclosporin A resistant. J. Virol. 79 5 (2005) 3211-3216
48. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332 4 (1995) 228-232
49. Krautkramer E., Giese S.I., Gasteier J.E., Muranyi W., and Fackler O.T. Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 78 8 (2004) 4085-4097
50. Lama J. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr. HIV Res. 1 2 (2003) 167-184
51. Lama J., Mangasarian A., and Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9 12 (1999) 622-631
52. Liu L.X., Heveker N., Fackler O.T., Arold S., Le Gall S., Janvier K., Peterlin B.M., Dumas C., Schwartz O., Benichou S., and Benarous R. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J. Virol. 74 11 (2000) 5310-5319
53. Liu X., Schrager J.A., Lange G.D., and Marsh J.W. HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations. J. Biol. Chem. 276 35 (2001) 32763-32770
54. Lu X., Wu X., Plemenitas A., Yu H., Sawai E.T., Abo A., and Peterlin B.M. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6 12 (1996) 1677-1684
55. Lu X., Yu H., Liu S.H., Brodsky F.M., and Peterlin B.M. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8 5 (1998) 647-656
56. Lundquist C.A., Tobiume M., Zhou J., Unutmaz D., and Aiken C. Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J. Virol. 76 9 (2002) 4625-4633
57. Madrid R., Janvier K., Hitchin D., Day J., Coleman S., Noviello C., Bouchet J., Benmerah A., Guatelli J., and Benichou S. Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. J. Biol. Chem. 280 6 (2005) 5032-5044
58. Mangasarian A., Piguet V., Wang J.K., Chen Y.L., and Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73 3 (1999) 1964-1973
59. Manninen A., Hiipakka M., Vihinen M., Lu W., Mayer B.J., and Saksela K. SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 250 2 (1998) 273-282
60. Michel N., Allespach I., Venzke S., Fackler O.T., and Keppler O.T. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr. Biol. 15 8 (2005) 714-723
61. Miller M.D., Warmerdam M.T., Gaston I., Greene W.C., and Feinberg M.B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179 1 (1994) 101-113
62. Muller B., Tessmer U., Schubert U., and Krausslich H.G. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. J. Virol. 74 20 (2000) 9727-9731
63. Muller B., Daecke J., Fackler O.T., Dittmar M.T., Zentgraf H., and Krausslich H.G. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 78 19 (2004) 10803-10813
64. Pandori M.W., Fitch N.J., Craig H.M., Richman D.D., Spina C.A., and Guatelli J.C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70 7 (1996) 4283-4290
65. Petit C., Buseyne F., Boccaccio C., Abastado J.P., Heard J.M., and Schwartz O. Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology 286 1 (2001) 225-236
66. Piguet V., Chen Y.L., Mangasarian A., Foti M., Carpentier J.L., and Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J. 17 9 (1998) 2472-2481
67. Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G., and Trono D. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2 3 (2000) 163-167
68. Renkema G.H., Manninen A., Mann D.A., Harris M., and Saksela K. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr. Biol. 9 23 (1999) 1407-1410
69. Roeth J.F., Williams M., Kasper M.R., Filzen T.M., and Collins K.L. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J. Cell Biol. 167 5 (2004) 903-913
70. Ross T.M., Oran A.E., and Cullen B.R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9 12 (1999) 613-621
71. Rucker E., Munch J., Wildum S., Brenner M., Eisemann J., Margolis L., and Kirchhoff F. A naturally occurring variation in the proline-rich region does not attenuate human immunodeficiency virus type 1 nef function. J. Virol. 78 18 (2004) 10197-10201
72. Saksela K., Cheng G., and Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14 3 (1995) 484-491
73. Sawai E.T., Baur A.S., Peterlin B.M., Levy J.A., and Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270 25 (1995) 15307-15314
74. Sawai E.T., Khan I.H., Montbriand P.M., Peterlin B.M., Cheng-Mayer C., and Luciw P.A. Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr. Biol. 6 11 (1996) 1519-1527
75. Schrager J.A., and Marsh J.W. HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 96 14 (1999) 8167-8172
76. Schwartz O., Marechal V., Danos O., and Heard J.M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69 7 (1995) 4053-4059
77. Schwartz O., Marechal V., Le Gall S., Lemonnier F., and Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2 3 (1996) 338-342
78. Sinclair E., Barbosa P., and Feinberg M.B. The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable. J. Virol. 71 5 (1997) 3641-3651
79. Spina C.A., Kwoh T.J., Chowers M.Y., Guatelli J.C., and Richman D.D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179 1 (1994) 115-123
80. Stamatatos L., and Cheng-Mayer C. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J. Virol. 67 9 (1993) 5635-5639
81. Stoddart C.A., Geleziunas R., Ferrell S., Linquist-Stepps V., Moreno M.E., Bare C., Xu W., Yonemoto W., Bresnahan P.A., McCune J.M., and Greene W.C. Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J. Virol. 77 3 (2003) 2124-2133
82. Stumptner-Cuvelette P., Morchoisne S., Dugast M., Le Gall S., Raposo G., Schwartz O., and Benaroch P. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U.S.A. 98 21 (2001) 12144-12149
83. Swingler S., Brichacek B., Jacque J.M., Ulich C., Zhou J., and Stevenson M. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424 6945 (2003) 213-219
84. Tobiume M., Lineberger J.E., Lundquist C.A., Miller M.D., and Aiken C. Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J. Virol. 77 19 (2003) 10645-10650
85. Tomiyama H., Fujiwara M., Oka S., and Takiguchi M. Cutting edge: epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication. J. Immunol. 174 1 (2005) 36-40
86. Welker R., Kottler H., Kalbitzer H.R., and Krausslich H.G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219 1 (1996) 228-236
87. Welker R., Harris M., Cardel B., and Krausslich H.G. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. J. Virol. 72 11 (1998) 8833-8840
88. Williams M., Roeth J.F., Kasper M.R., Filzen T.M., and Collins K.L. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J. Virol. 79 1 (2005) 632-636
89. Witte V., Laffert B., Rosorius O., Lischka P., Blume K., Galler G., Stilper A., Willbold D., D'Aloja P., Sixt M., Kolanus J., Ott M., Kolanus W., Schuler G., and Baur A.S. HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Mol. Cell 13 2 (2004) 179-190
90. Wolf D., Witte V., Laffert B., Blume K., Stromer E., Trapp S., d'Aloja P., Schurmann A., and Baur A.S. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat. Med. 7 11 (2001) 1217-1224
91. Xu X.N., Screaton G.R., Gotch F.M., Dong T., Tan R., Almond N., Walker B., Stebbings R., Kent K., Nagata S., Stott J.E., and McMichael A.J. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186 1 (1997) 7-16
92. Xu X.N., Laffert B., Screaton G.R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A.J., and Baur A.S. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 189 9 (1999) 1489-1496
93. Yamada T., Kaji N., Odawara T., Chiba J., Iwamoto A., and Kitamura Y. Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J. Virol. 77 2 (2003) 1589-1594
94. Zhou J., and Aiken C. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope. J. Virol. 75 13 (2001) 5851-5859